<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-metformin.xml</id>
  <title>Recalls Watch: Metformin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-metformin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-04-16T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96313/</id>
    <title>A-S Medication Solutions LLC: METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG</title>
    <link href="https://recalls.watch/recall/fda/96313/"/>
    <updated>2025-04-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96082/</id>
    <title>Granules Pharmaceuticals Inc.: Metformin Hydrochloride Extended-Release Tablets</title>
    <link href="https://recalls.watch/recall/fda/96082/"/>
    <updated>2025-01-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-shoppers-plaza-issues-voluntary-nationwide-recall-fouzee-sugarlin-herbal-formula/</id>
    <title>Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide</title>
    <link href="https://recalls.watch/recall/fda/n-shoppers-plaza-issues-voluntary-nationwide-recall-fouzee-sugarlin-herbal-formula/"/>
    <updated>2024-12-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Product contains undeclared Metformin and Glyburide</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/87833/</id>
    <title>Preferred Pharmaceuticals, Inc.: Preferred Pharmaceuticals Inc.</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=87833"/>
    <updated>2021-05-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/87210/</id>
    <title>Nostrum Laboratories Inc: Metformin Hydrochloride Extended-Release Tablets</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=87210"/>
    <updated>2021-02-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/87080/</id>
    <title>Nostrum Laboratories Inc: Metformin Hydrochloride Extended-Release Tablets</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=87080"/>
    <updated>2021-01-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/86653/</id>
    <title>Nostrum Laboratories Inc: Metformin Hydrochloride Extended-Release Tablets and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=86653"/>
    <updated>2020-11-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/86593/</id>
    <title>Denton Pharma, Inc.: Metformin Hydrochloride Extended-Release Tablets USP 750 mg and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=86593"/>
    <updated>2020-11-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-marksans-pharma-limited-issues-expansion-voluntary-nationwide-recall-metformin-h/</id>
    <title>Marksans Pharma Limited: Time-Cap Labs Inc.: Metformin Hydrochloride for Extended-Release Tablets, USP 500 mg and 750 mg</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marksans-pharma-limited-issues-expansion-voluntary-nationwide-recall-metformin-hydrochloride"/>
    <updated>2020-10-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-riomet-ertm/</id>
    <title>Sun Pharmaceutical Industries: Riomet ER: Metformin Hydrochloride for Extended-Release Oral Suspension</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-riomet-ertm-metformin"/>
    <updated>2020-09-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-bayshore-pharmaceuticals-llc-issues-voluntary-nationwide-recall-metformin-hydroc/</id>
    <title>Bayshore Pharmaceuticals, LLC: Metformin Hydrochloride Extended-Release Tablets USP, 500 mg &amp; 750 mg</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bayshore-pharmaceuticals-llc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended"/>
    <updated>2020-08-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/85986/</id>
    <title>Granules Pharmaceuticals Inc: Metformin Hydrochloride Extended-Release Tablets USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=85986"/>
    <updated>2020-07-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-metformin-hydroch/</id>
    <title>Lupin Pharmaceuticals, Inc.: Lupin: Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-metformin-hydrochloride-extended"/>
    <updated>2020-07-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: N-Nitrosodimethylamine (NDMA) Impurity</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/85781/</id>
    <title>Amneal Pharmaceuticals of New York, LLC: amneal Metformin Hydrochloride Extended-Release Tablets and 11 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=85781"/>
    <updated>2020-07-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hyd/</id>
    <title>Teva Pharmaceuticals USA Inc.: Actavis: Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended"/>
    <updated>2020-06-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to detection of N-Nitrosodimethylamine (NDMA)</summary>
  </entry>
</feed>
